chr16:23603170:> Detail (hg38) (PALB2)

Information

Genome

Assembly Position
hg19 chr16:23,614,491-23,652,631 
hg38 chr16:23,603,170-23,641,310

HGVS

Type Transcript Protein
Summary

MGeND

Clinical significance
Variant entry
GWAS entry
Disease area statistics Show details

Frequency

[No Data.]

Prediction

[No Data.]

ClinVar

Clinical Significance
Review star [No Data.]
Show details
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
Disease Drug EL ET ED CS VO TR Pubmed Links
pancreatic cancer Mitomycin C Predictive Supports Sensitivity/Response Somatic 4 21135251 Detail
prostate cancer Olaparib C Predictive Supports Sensitivity/Response Somatic 3 26510020 Detail
DisGeNET
[No Data.]
Annotation

Annotations

DescrptionSourceLinks
In a patient with gemcitabine-refractory pancreatic cancer, a tumor-derived xenograft was found to b... CIViC Evidence Detail
From 14 prostate cancer patients (88%) who had a response to olaparib, 7 patients had BRCA2 loss (4 ... CIViC Evidence Detail

Overlapped Transcript Coordinates

Gene Transcript ID Exon Number Chromosome Start Stop Type Amino Mutation Transcript Position Links

Overlapped Transcript

Gene Transcript ID Chromosome Start Stop Links
Gene
-
Genome
hg38
Position
chr16:23,603,170-23,641,310
Variant Type
snv
Variant (CIViC) (CIViC Variant)
BIALLELIC INACTIVATION
Transcript 1 (CIViC Variant)
ENST00000261584.4
Variant URL (CIViC Variant)
https://civic.genome.wustl.edu/links/variants/532
Genome browser